Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Russom (Asmara, Eritrea), K. Verhamme (Rotterdam, Netherlands), L. Karimi (Rotterdam, Netherlands), H. Ahmed (Asmara, Eritrea). Nature, Magnitude and Risk Factors of Adverse Drug Reactions in Multidrug Resistant TB Patients in Eritrea. 4746

Member's Comments

No comment yet.

Related content which might interest you: Socioeconomic Conditions Contributing to Multi Drug Resistant (MDR) and Extremely Drug Resistant(XDR) Tuberculosis Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Risk Factors for Mortality of COVID-19 Confirmed Cases Admitted at Lung Center of the Philippines Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021 Prevalence of Multidrug Resistant Tuberculosis among TB Patients in Malaysia. Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 Clinical Features Associated with Linezolid Resistance Among Multidrug Resistant Tuberculosis Patients at a Tertiary Care Hospital in Mumbai, India Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Evaluation of 123 Cases with MDR TB (Multidrug Resistant Tuberculosis) Treatment Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study. Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020 Higher Age Puts Lung-Cancer Patients at Risk for Not Receiving Anti-cancer Treatment Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019 Results of the 2003–2004 TB Drug Resistance Survey in Romania Source: Eur Respir J 2006; 28: Suppl. 50, 457s Year: 2006 Meta-analysis on the Effect of Current Smoking on the Risk of Developing Community Acquired Pneumonia Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) Year: 2018 Exposure/Effect Biomarkers and Respiratory Adverse Outcomes in Metal Plating Workers Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation Year: 2018 Incidence of Cardiac Complications after Hospitalisation for Community Acquired Pneumonia: A Large Population-based Cohort Study Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Immune-Related Adverse Events Associated with Immune Checkpoint Blockade in Lung Cancer – A restrospective study. Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Socioeconomic Status and Cleaning: Major Factors Affecting Asthma Control Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020 PES Pathogens in Elderly Patients with Acquired Pneumonia in the Community Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Evaluation of concurrent use of Tobacco products (Water Pipe and Cigarettes) and Associated Factors in Adults in Tehran Source: International Congress 2017 – Global epidemiologic data on smoking Year: 2017 Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 Early Fever Associated with Clinical Outcomes in Patients with Coronavirus Disease 2019 Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021